Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
On this Biotech Investing tag page, 5 recent articles cover innovative biotech stocks, Agios moves, Arcellx updates, Cogent Biosciences and more, giving you quick, actionable finance insights.
120 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Biotech stocks can swing on earnings surprises. This article explains why lenz therapeutics stock crashed, what it me...
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
A disciplined investor asks: can a modest, cash-backed bet on a distressed stock generate alpha? This article breaks ...
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
VR Adviser recently disclosed a substantial sale of Ocular Therapeutix shares, triggering questions about what it mea...
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A bold investment in a brain health biotech signals conviction in early-stage science. This article breaks down what ...
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...